2-6863503-T-C
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_207315.4(CMPK2):āc.751A>Gā(p.Lys251Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000322 in 1,614,090 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_207315.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CMPK2 | NM_207315.4 | c.751A>G | p.Lys251Glu | missense_variant | 2/5 | ENST00000256722.10 | NP_997198.2 | |
CMPK2 | NM_001256477.1 | c.751A>G | p.Lys251Glu | missense_variant | 2/4 | NP_001243406.1 | ||
CMPK2 | NM_001256478.1 | c.751A>G | p.Lys251Glu | missense_variant | 2/4 | NP_001243407.1 | ||
CMPK2 | NR_046236.2 | n.286A>G | non_coding_transcript_exon_variant | 2/5 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.00000801 AC: 2AN: 249566Hom.: 0 AF XY: 0.00000739 AC XY: 1AN XY: 135392
GnomAD4 exome AF: 0.0000342 AC: 50AN: 1461884Hom.: 0 Cov.: 30 AF XY: 0.0000303 AC XY: 22AN XY: 727242
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152206Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74364
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2024 | The c.751A>G (p.K251E) alteration is located in exon 2 (coding exon 2) of the CMPK2 gene. This alteration results from a A to G substitution at nucleotide position 751, causing the lysine (K) at amino acid position 251 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at